The author's reply to comment on ‘psoriasis/inflammatory bowel diseases: a time to solve the liaison’
C.X. Kou
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
The first two authors contribute equally to this study.Search for more papers by this authorY.Y. Zhang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
The first two authors contribute equally to this study.Search for more papers by this authorQ.T. Kong
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorJ. li
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorM. Zhang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorG.W. Li
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000 China
Search for more papers by this authorJ. Chen
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorF. Liu
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorCorresponding Author
J.A. Ren
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000 China
Correspondence: J.A. Ren and H. Sang. E-mails: [email protected] and [email protected]Search for more papers by this authorCorresponding Author
H. Sang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Correspondence: J.A. Ren and H. Sang. E-mails: [email protected] and [email protected]Search for more papers by this authorC.X. Kou
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
The first two authors contribute equally to this study.Search for more papers by this authorY.Y. Zhang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
The first two authors contribute equally to this study.Search for more papers by this authorQ.T. Kong
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorJ. li
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorM. Zhang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorG.W. Li
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000 China
Search for more papers by this authorJ. Chen
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorF. Liu
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Search for more papers by this authorCorresponding Author
J.A. Ren
Department of Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, 210000 China
Correspondence: J.A. Ren and H. Sang. E-mails: [email protected] and [email protected]Search for more papers by this authorCorresponding Author
H. Sang
Department of Dermatology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China
Correspondence: J.A. Ren and H. Sang. E-mails: [email protected] and [email protected]Search for more papers by this author
References
- 1Abdelmaksoud A. Psoriasis/Inflammatory bowel diseases: a time to solve the liaison. J Eur Acad Dermatol Venereol 2018. https://doi.org/10.1111/jdv.14919. [Epub ahead of print].
- 2Kou CX, Zhang YY, Li GW et al. Mucocutaneous manifestations of inflammatory bowel disease in central China: a single-center study. J Eur Acad Dermatol Venereol 2017. https://doi.org/10.1111/jdv.14720. [Epub ahead of print].
- 3Hindryckx P, Novak G, Costanzo A et al. Disease-related and drug-induced skin manifestations in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2017; 11: 203–214.
- 4Marzano AV, Ishak RS, Saibeni S et al. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet′ s syndrome: a comprehensive review and disease classification criteria[J]. Clin Rev Allergy Immunol, 2013; 45: 202–210.
- 5Fiorino G et al. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009; 29: 921–927.
